CAPITAL FLOWS BETA

THE CAPITAL BEHIND THE DEAL

Arlequin AI (ARLEQUIN S.A.S.)

France · 2026-09-10 · Series A

€28MAnnounced transaction total, not an investor contribution
Paris, FranceCompany location
1 mappedSource-linked participants; coverage may be partial
Lead / transaction context
redalpine and OTB Ventures
Recorded investor context
Participants include Bpifrance’s Defence Innovation Fund, Vsquared Ventures, 10x Founders, Xavier Niel and ZEBOX.
Public participation
Recorded · Equity
Sector
Artificial intelligence
Explore this deal on the map →

Source-linked participants

redalpine

Zug, Switzerland → Arlequin AI (ARLEQUIN S.A.S.)

Recorded participation

Participation source ↗ · Investor location source ↗

Sources and limits

Open announcement source ↗ · Company location source ↗

Lines show source-supported participation between approximate city-centre locations. An investor point may represent a disclosed office or a fund manager, not the fund domicile or payment origin. Individual contributions are disclosed only where separately sourced; the round total is never divided between investors. The mapped participants may be a subset of the announced syndicate. Source checked 2026-10-23T15:06:37.958Z.

Share on LinkedIn ↗Download branded PNG

Follow Capital Flows on LinkedIn ↗

Related in our coverage

France · 2026-10-21

Pigment

US$250M

Growth · announced transaction total

Recorded public participation. Explore the role and round-specific sources.

Source ↗

France · 2026-10-13

Doctolib

Undisclosed

Other · announced transaction total

Explore named investors, the announcement source and available map relationships.

Source ↗

France · 2026-10-06

Wiremind

€35M

Growth · announced transaction total

Recorded public participation. Explore the role and round-specific sources.

Source ↗

Explore this announcement week →

Share a source-linked view

Link to this deal or its selected map view. Use the branded PNG above with a link back to the source page; do not imply that lines show individual investment amounts.